A combination of drugs widely used in anti-aging studies seems to compromise the function of the brain’s myelin-making cells and cause profound myelin loss, according to the findings of a new study in mice and lab-grown cells. The dual treatment, which combines dasatinib and quercetin, also known as D+Q, caused oligodendrocytes — the cells that […]
The post Common anti-aging drugs may damage brain’s protective coating appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com